NEW YORK (GenomeWeb News) - Agendia has acquired ISO/IEC 17025:2005 accreditation for its CupPrint microarray service from the Dutch Accreditation Council, the company said today.
The company was granted ISO 17025 accreditations for MammaPrint, a microarray-based breast cancer diagnostic, in Sept. 2005. According to Agendia, it is the first company to receive this accreditation for the test.
CupPrint is a test for cancer of unknown primary.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.